Atomoxetine
Effect Profile
Describes the acute effect. This profile does not influence the OpenMind Score.
No effect profiles yet. Describe the acute effect without changing the long-term score.
Please log in to add effect details
Log inDescription
Atomoxetine, sold under the brand name Strattera, is a selective norepinephrine reuptake inhibitor (SNRI) used to treat attention deficit hyperactivity disorder (ADHD). Its effectiveness is comparable to the commonly prescribed stimulant methylphenidate.
Dosage
Oral
| Light | Common | Strong |
|---|---|---|
| 10-18 mg | 18-40 mg | 40-80 mg+ |
Duration
Oral
Detection Times
| Method | Detection Window |
|---|---|
| Blood | 12–24 hours |
| Urine | 1–3 days |
Note: Non-stimulant ADHD medication (Strattera). NOT part of standard drug panels. Does not cause false positives for amphetamines.
Community Experiences
Share a single experience — does not affect the OpenMind Score.
Comments
Please log in to comment
Log inEverything in OpenMind
Track your use, check combinations and find safer use tips – even offline.
No comments yet.